The latest closing stock price for Bellevue Life Sciences Acquisition as of November 07, 2024 is 11.05.
An investor who bought $1,000 worth of Bellevue Life Sciences Acquisition stock at the IPO in 2023 would have $94 today, roughly 0 times their original investment - a 4.60% compound annual growth rate over 2 years.
The all-time high Bellevue Life Sciences Acquisition stock closing price was 11.05 on October 31, 2024.
The Bellevue Life Sciences Acquisition 52-week high stock price is 11.60, which is 5% above the current share price.
The Bellevue Life Sciences Acquisition 52-week low stock price is 10.42, which is 5.7% below the current share price.
The average Bellevue Life Sciences Acquisition stock price for the last 52 weeks is 10.72.
An investor who bought $1,000 worth of Bellevue Life Sciences Acquisition stock at the IPO in 2023 would have $94 today, roughly 0 times their original investment - a 4.60% compound annual growth rate over 2 years.
The all-time high Bellevue Life Sciences Acquisition stock closing price was 11.05 on October 31, 2024.
The Bellevue Life Sciences Acquisition 52-week high stock price is 11.60, which is 5% above the current share price.
The Bellevue Life Sciences Acquisition 52-week low stock price is 10.42, which is 5.7% below the current share price.
The average Bellevue Life Sciences Acquisition stock price for the last 52 weeks is 10.72.